Sexual & Reproductive Health
A negative fetal fibronectin can avoid potentially harmful interventions
Published in Women's Health Weekly, January 26th, 2006
In a recently published article, scientists in the United States conducted a study "[t]o determine if fetal fibronectin can be used in a clinical setting to predict preterm birth and guide clinical management."
"We implemented a clinical protocol using the rapid fetal fibronectin test for patients presenting with symptoms Of preterm labor. Adherence to the clinical pathway was at the discretion of the practitioner," wrote G.K. Swamy and colleagues, Duke University.
The authors explained, "Subjects who met the inclusion criteria (n=404) were divided into 2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cancer Risk Factors
Weight change over adult life may not adversely affect cancer incidence in women - Cardiac Rehabilitation
Completion of cardiac rehabilitation results in significant benefits for women - Heart Failure
Mild hypertension increases risk of heart failure in older women - Obesity
Women with higher adiposity gain greatest benefit from weekly walking regime - Obstetrics
Perinatal complications linked to later development of eating disorders - Abortion
Studies evaluate misoprostol use to terminate pregnancies in Latin America - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
